HomeNewsBusinessStartupCovid will speed up adoption of ecommerce: Report

Covid will speed up adoption of ecommerce: Report

With the disease making people wary of stepping out, a report by Unicommerce has highlighted how Indians are opening up to ordering more online; small towns are also driving adoption with much faster growth compared to metros.

August 20, 2020 / 13:52 IST
Story continues below Advertisement

While Covid-19 has affected every business across the country, as a mode of consumption, ecommerce could grow much faster after the pandemic, said a report released by ecommerce software platform Unicommerce on Thursday.

Quoting pre-Covid reports, which said that the ecommerce market in India would be worth $200 billion in size by 2027, Unicommerce said that given the digitisation due to Covid, this number would be attained much faster.

Story continues below Advertisement

Multiple reasons will drive this adoption, starting from consumers being wary of stepping out of their houses, online orders being fulfilled faster and more efficiently and overall digitisation of the country. Further better use of technology can ensure that consumers order the right product and the need for returns is reduced.

Small-business digitisation

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show